Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 2, 2010, Pages 249-259

  Mita, Yuichiro ^a   Yasuda, Yukiko ^a   Sakai, Akiko ^a   Yamamoto, Hiromasa ^a   Toyooka, Shinichi ^a   Gunduz, Mehmet ^a   Tanabe, Shunsuke ^a   Naomoto, Yoshio ^a   Ouchida, Mamoru ^a   Shimizu, Kenji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cancer; PTPN13; PTPRJ; SNP

Indexed keywords

ARGININE; ASPARTIC ACID; GLUTAMINE; ISOLEUCINE; METHIONINE; PROTEIN TYROSINE PHOSPHATASE; TYROSINE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; PROLINE; PTPN13 PROTEIN, HUMAN; PTPRJ PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; ETHNIC GROUP; GENE; GENE FREQUENCY; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; JAPAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PTPN13 GENE; PTPRJ GENE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; COLORECTAL TUMOR; ESOPHAGUS TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; INCIDENCE; LUNG TUMOR; MALE; MIDDLE AGED; NEOPLASM; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ARGININE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMINE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; ISOLEUCINE; JAPAN; LUNG NEOPLASMS; MALE; METHIONINE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLINE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 74049111302     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0656-7     Document Type: Article

References (31)

1. Abaan OD, Toretsky JA (2008) PTPL1: a large phosphatase with a split personality. Cancer Metastasis Rev 27:205-214.
2. Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946-953.
3. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Møller NP (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21:7117-7136.
4. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Cuppen E, Nagata S, Wieringa B, Hendriks W (1997) No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J Biol Chem 272:30215-30220.
6. de la Fuente-García MA, Nicolás JM, Freed JH, Palou E, Thomas AP, Vilella R, Vives J, Gayá A (1998) CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91:2800-2809.
7. Erdmann KS (2003) The protein tyrosine phosphatase PTP-basophil/basophil- like interacting proteins and molecular functions. Eur J Biochem 270:4789-4798.
8. Erichsen HC, Chanock SJ (2004) SNPs in cancer research and treatment. Br J Cancer 90:747-751.
9. Foehr ED, Lorente G, Vincent V, Nikolich K, Urfer R (2005) FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS. J Neurooncology 74:241-248.
10. Freiss G, Vignon F (2004) Protein tyrosine phosphatases and breast cancer. Crit Rev Oncol Hematol 52:9-17.
11. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161:793-804.
12. Gross C, Heumann R, Erdmann KS (2001) The protein kinase C-related kinase PRK2 interacts with the protein tyrosine phosphatase PTP-BL via a novel PDZ domain binding motif. FEBS Lett 496:101-104.
13. Herrmann L, Dittmar T, Erdmann KS (2003) The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis. Mol Cell Biol 14:230-240.
14. Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L, Fusco A (2004) The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene 23:8432-8438.
15. Ivanov VN, Ronai Z, Hei TK (2006) Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis. J Biol Chem 281:1840-1852.
16. Kachel N, Erdmann KS, Kremer W, WolV P, Gronwald W, Heumann R, Kalbitzer HR (2003) Structure determination and ligand interactions of the PDZ2b domain of PTP-Bas (hPTP1E): splicinginduced modulation of ligand specificity. J Mol Biol 334:143-155.
17. Kellie S, Craggs G, Bird IN, Jones GE (2004) The tyrosine phosphatase DEP-1 induces cytoskeletal rearrangements, aberrant cell-substratum interactions and a reduction in cell proliferation. J Cell Sci 117:609-618.
18. Koh H, Lee KH, Kim D, Kim S, Kim JW, Chung J (2000) Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factorinduced protein kinase C-related kinase 2 (PRK2) cleavage. J Biol Chem 275:34451-34458.
19. Lesueur F, Pharoah PD, Laing S, Ahmed S, Jordan C, Smith PL, Luben R, Wareham NJ, Easton DF, Dunning AM, Ponder BA (2005) Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Hum Mol Genet 14:2349-2356.
20. Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P, Corsaro A, Iuliano R, Fusco A, Zona G, Spaziante R, Florio T, Schettini G (2004) The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. J Biol Chem 279:29004-29012.
21. Nishimoto S, Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7:782-786.
22. Ostman A, Yang Q, Tonks NK (1994) Expression of DEP-1, a receptor- like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA 91:9680-9684.
23. Palka HL, Park M, Tonks NK (2003) Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem 278:5728-5735.
24. Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. New Eng J Med 358:2796-2803.
25. Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikós T, Klous AM, Tripodis N, Perrakis A, Boerrigter L, Groot PC, Lindeman J, Mooi WJ, Meijjer GA, Scholten G, Dauwerse H, Paces V, van Zandwijk N, van Ommen GJ, Demant P (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31:295-300.
26. Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, Meijer G, Demant P (2003) LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 22:3472-3474.
27. Takahashi T, Takahashi K, Mernaugh RL, Tsuboi N, Liu H, Daniel TO (2006) A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood 108:1234-1242.
28. Villa F, Deak M, Bloomberg GB, Alessi DR, van Aalten DM (2005) Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket. J Biol Chem 280:8180-8187.
29. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, Ptak J, Silliman N, Peters BA, van der Heijden MS, Parmigiani G, Yan H, Wang TL, Riggins G, Powell SM, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304:1164-1166.
30. Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, Chang YS, Chen CL, Chang CF, Chen DS, Chen PJ (2006) Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Clin Cancer Res 12:1097-1108.
31. Zhu JH, Chen R, Yi W, Cantin GT, Fearns C, Yang Y, Yates JR 3rd, Lee JD (2008) Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene 27:2525-2531.